IP Library Granted Patent US 9,150,534
Granted Patent B2
US 9,150,534 · App. 13/780,929 · Granted Oct 6, 2015

Prodrugs of fluorinated mevalonates to inhibit the mevalonate pathway of

Inventors: Richard B. Silverman (Winnetka, IL); Mizuki Watanabe (Kyoto, JP); Soosung Kang (Wilmette, IL); Thomas S. Leyh (Katonah, NY)
Assignees: Northwestern University; Albert Einstein College of Medicine of Yeshiva University
C07D319/06C07C69/675C07C235/06C07D309/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,150,534
App. No.
13/780,929
Granted
Oct 6, 2015
Kind
B2
Abstract

Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.

Claims (28)

1. A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, alkanoyloxy, cycloalkyl, mono- and polyfluoro-substituted cycloalkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, and mono- and polyfluoro-substituted arylalkyl moieties.

2. The compound of claim 1 wherein X is selected from NH and O; and R 1 is selected from fluoromethyl and trifluoromethyl moieties.

3. The compound of claim 2 wherein R 2 is selected from mono- and polyfluoro-substituted arylalkyl moieties.

4. The compound of claim 3 wherein R 2 is selected from mono- and difluoro-substituted benzyl moieties.

5. The compound of claim 1 in at least one of human plasma and contact with an enzyme in a streptococcal mevalonate biosynthetic pathway.

6. A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, and mono- and polyfluoro-substituted arylalkyl moieties.

7. The compound of claim 6 wherein X is selected from NH and O; and R 1 is selected from fluoromethyl and trifluoromethyl moieties.

8. The compound of claim 7 wherein R 2 is selected from aryl, mono- and polyfluoroaryl, arylalkyl, mono- and polyfluoroarylalkyl moieties.

9. The compound of claim 8 wherein R 2 is selected from phenyl, mono- and polyfluorophenyl, benzyl, monofluorobenzyl and polyfluorobenzyl moieties.

10. A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties; and R 3 and R 4 are independently selected from H, alkyl, C 1 -C 2 alkoxyalkyl, aryl and arylalkyl moieties.

11. The compound of claim 10 wherein X is selected from NH and O; and R 1 is independently selected from fluoromethyl and trifluoromethyl moieties.

12. The compound of claim 11 where R 2 is selected from arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties.

13. The compound of claim 10 wherein R 3 and R 4 are independently selected from H and alkyl moieties.

14. The compound of claim 13 wherein at least one of R 3 and R 4 is methyl.

15. A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties; and R 3 and R 4 are independently selected from H, acetyl, propionyl and C 1 -C 2 alkoxyalkyl moieties, providing compound is not

16. The compound of claim 15 wherein X is selected from NH and O; and R 1 is selected from fluoromethyl and trifluoromethyl moieties.

17. The compound of claim 16 wherein R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties.

18. The compound of claim 15 wherein X is O; R 2 is selected from alkyl, aryl and arylalkyl moieties; and R 3 and R 4 are independently selected from H and acetyl moieties.

19. The compound of claim 18 wherein at least one of R 3 and R 4 is acetyl.

20. A compound of a formula

wherein R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from acetyl, propionyl and C 1 -C 2 alkoxyalkyl moieties, providing said compound is not

21. The compound of claim 20 wherein R 1 is selected from fluoromethyl and trifluoromethyl moieties.

22. The compound of claim 21 wherein R 2 is selected from acetyl and propionyl moieties.

23. The compound of claim 22 wherein R 2 is acetyl.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2016
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 037475/0524 →
CONFIRMATORY LICENSE Recorded Nov 13, 2015
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037109/0757 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2015
From: LEYH, THOMAS S.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 035457/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2013
From: SILVERMAN, RICHARD B.; WATANABE, MIZUKI; KANG, SOOSUNG
To: NORTHWESTERN UNIVERSITY
Reel/Frame 030198/0646 →
Continuity (2)
Provisional Application 61604261 · Feb 28, 2012
Related Publication 20130245284A1 · Sep 19, 2013